Product NDC: | 0052-0273 |
Proprietary Name: | NuvaRing |
Non Proprietary Name: | etonogestrel and ethinyl estradiol |
Active Ingredient(s): | 2.7; 11.7 mg/1; mg/1 & nbsp; etonogestrel and ethinyl estradiol |
Administration Route(s): | VAGINAL |
Dosage Form(s): | INSERT, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0052-0273 |
Labeler Name: | Organon Pharmaceuticals USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021187 |
Marketing Category: | NDA |
Start Marketing Date: | 20011003 |
Package NDC: | 0052-0273-85 |
Package Description: | 5 POUCH in 1 BOX (0052-0273-85) > 1 INSERT, EXTENDED RELEASE in 1 POUCH (0052-0273-81) |
NDC Code | 0052-0273-85 |
Proprietary Name | NuvaRing |
Package Description | 5 POUCH in 1 BOX (0052-0273-85) > 1 INSERT, EXTENDED RELEASE in 1 POUCH (0052-0273-81) |
Product NDC | 0052-0273 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | etonogestrel and ethinyl estradiol |
Dosage Form Name | INSERT, EXTENDED RELEASE |
Route Name | VAGINAL |
Start Marketing Date | 20011003 |
Marketing Category Name | NDA |
Labeler Name | Organon Pharmaceuticals USA |
Substance Name | ETHINYL ESTRADIOL; ETONOGESTREL |
Strength Number | 2.7; 11.7 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |